Acute Oncology. The National Picture 16/07/2014. Philippa Jones. Acute Oncology Forum Lead. Macmillan Associate Acute Oncology Nurse Advisor
|
|
- Hollie Sparks
- 5 years ago
- Views:
Transcription
1 Acute Oncology The National Picture 1 Philippa Jones Acute Oncology Forum Lead Macmillan Associate Acute Oncology Nurse Advisor United Kingdom Acute Oncology Nursing Society 2 1
2 Acute Oncology People with cancer often develop new and acute problems which require an urgent response, either as a consequence of their cancer illness or the treatment itself. Professor Sir Mike Richards (Royal College of Physicians 2012) 3 National Drivers 4 2
3 NPSA and NCEPOD Patients suffering from acute oncology emergencies not recognised, or appropriate treatment delayed by; Primary care teams Ambulance personnel Emergency care teams Oncology teams and Patients themselves 5 Emergency care NCEPOD 49% having room for improvement and 8% receiving less than satisfactory care. NCAG- There were 273,000 emergency admissions with a diagnosis of cancer in 2006/7. This is roughly equivalent to 750 emergency admissions each day across England. A typical Trust may have five emergency admissions with cancer per day 6 3
4 The National Chemotherapy Action Group (NCAG), guided partly by reports from NCEPOD and NPSA and from previous cancer peer review results, recommended that a more systematic approach should be taken to dealing with cancer-related emergencies. These recommendations have been embodied in the concept of the 'Acute Oncology Service'. 7 Acute Oncology Services Acute oncology services are being implemented at all acute trusts that accept unplanned and emergency cancer admissions. They centre on a team consisting of one or more nurse specialists or nurse practitioners with dedicated availability Monday to Friday and from one or more oncologist. These professionals interface with acute teams, specialist palliative care and others to improve the coordination of care with earlier access to the relevant specialist advice. They also have key roles in education and audit. 8 4
5 - Acute Oncology Nurse Who are Acute Oncology Patients? Two Patient Groups : 1. Patients with potentially acute complications of their cancer treatment.* 2. Patients potentially suffering from certain emergencies caused by the disease process itself whether the primary site is known, unknown or presumed * non-surgical treatment 10 5
6 Key Features of an Acute Oncology Service: Early review by an oncologist or acute oncology nurse specialist (within 24 hours) 24/7 access to telephone advice from an oncologist Fast track clinic access from A&E or MAU Access to information on individual patients across the Trust Protocols for the management of oncological emergencies and referral pathways from A&E and acute admissions unit Specific pathways for the investigation and treatment of malignant spinal cord compression Early management of MUO/CUP patients 11 Key Features of an Acute Oncology Service: Early review by an oncologist or acute oncology nurse specialist (within 24 hours) 24/7 access to telephone advice from an oncologist Fast track clinic access from A&E or MAU Access to information on individual patients across the Trust Protocols for the management of oncological emergencies and referral pathways from A&E and acute admissions unit Specific pathways for the investigation and treatment of malignant spinal cord compression Early management of MUO/CUP patients 12 6
7 Where are we now? What s out there to help at the moment? How can we promote a culture of Acute Oncology and support each other? How can we influence change? UK Picture Trusts throughout the UK are developing specialist acute oncology advice and assessment services in response to concerns raised in 2008 by the NCEPOD report. Scotland a number of acute oncology projects and the development of a national helpline service. Northern Ireland.aspects such as the adoption of UKONS triage tool. Wales. Acute oncology projects led by the cancer networks and UKONS triage tool. England.National uptake guided by the Peer Review measures. 7
8 Internationally UK leading the way! Hong Kong Australia Canada New Zealand Malta Ireland Saudi Arabia Is it worth it? Admission avoidance Decreased Length of stay Reduced investigations/intervention My favourites: Improvement in quality and safety Increased patient satisfaction Increased professional satisfaction 8
9 Peer Review Love it or loathe it Time consuming Loathe It? Prescriptive Directed at process and not outcomes 9
10 Love It? Describes the structure/framework of a service - development A framework for review monitoring A benchmarking tool comparison Evidence Education How reliable is the process? Can we be trusted to self assess? Can we be rely on our trust/network colleagues to assess us? 10
11 Immediate Risks And Serious Concerns Services with IRs (SA/IV) Services with IRs (PR) % services with IRs Services with SCs (SA/IV) Services with SCs (PR) % services with SC AO MDT N/A 8 % 50 N/A 27 % % % Specialist AO/MDT N/A 0 3 N/A 21% % % Generic AO N/A 8% 54 N/A 28% % % AO In- Patient MDT N/A 8 % 52 N/A 27% % % Acute Oncology Immediate Risks There are still many non-functioning and totally non-compliant Acute Oncology Services without sufficient planning to address this. There is a lack of staffing. There are problems across the board regarding the core members of the MDTs. Lack of appropriate training. Lack of access to an oncologist within 24hrs of presentation. Lack of a fully functioning electronic flagging system. Lack of administration support. 1 hour Antibiotic pathway in A&E not being observed. 11
12 Acute oncology immediate risks MSCC pathways are not sufficiently robust and in some instances have no formal documented pathway at all, resulting in patients not being discussed by appropriate clinical teams which has high levels of risk for this group of patients. Neutropenic sepsis pathways not being reviewed or audited and so remain unclear as to whether safe and effective care is being provided for these patients. Lack of engagement with A&E departments. Lack of engagement from Oncologists regarding the setup of the Acute oncology service No CUP (Cancer of Unknown Primary) service. Mismanagement and patient safety issues regarding there being two sets of notes (Main medical and Oncology) for patients receiving treatment which may not be available to A&E department. Acute Oncology Good Practice Co-ordination and leadership role of the AOS nurse. Trust-wide engagement from clinicians and nurses. Raising the profile of the acute oncology service within trusts and externally. The use of patient group directives for nurses and placing of sepsis trolleys in appropriate areas to improve time to first dose of antibiotics. Innovative and comprehensive training methods with the development of e-learning packages. Web based systems for well-developed policies and protocols with a variety of promotional screensavers. 12
13 Peer Review Is Here To Stay New Measures this year reinforced the role of the network groups in the development and review of acute oncology services. Outcomes Lives of people affected by cancer will be improved through using the AOS Service by: Reduction in length of stay Reduction in emergency admissions Timely and appropriate management of patients with potential neutropenic sepsis Timely review and assessment by members of the Acute Oncology service Reduction in unnecessary clinical investigations Reduction in waiting times Increase in patient satisfaction Reduction in complaints Reduction in avoidable deaths within 30 days of systemic anti-cancer therapy (NCEPOD 2009) 13
14 Forward Do you have defined outcome measures for your service? Would it be better to have nationally agreed outcome measures? Could you improve your Peer review? National Group Evidence Annual Peer Review against the measures for Acute Oncology Patient satisfaction Survey results Use of the Acute Oncology Services monitoring and outcome measures for Acute Oncology This data and information will be presented regularly in an agreed format at an agreed governance group meeting and any concerns regarding existing quality or concerns about maintaining quality will be escalated appropriately. The Acute Oncology Team will produce an annual report utilising the information listed above to evaluate the efficiency and quality of the service. 14
15 Data collection Why do we want/need to collect data Demonstrate outcomes and effectiveness Demonstrate financial aspects of service Demonstrate need for service expansion or improvement Demonstrate service demands Highlight common problems Evidence of practice - good and bad 15
16 Data collection National outcome measures enabling us to compare and not Local value how are we doing? National value how are we all doing? Do we have a problem or do we all have a problem How can we fix it? Data is crucial & powerful? What's out there to help A number a basic access data bases developed locally and available for sharing Assessment tools and log sheets for data collection Somerset Data Base working on an Acute Oncology Module to cover Acute Oncology,MSCC and MUO/CUP. 16
17 The future Many of us are looking to build upon existing developments and utilise existing good practice. There is also recognition that the standardisation of training and patient management in the acute setting is a sensible strategy to support safe, high quality care. And it also saves valuable time and energy! Acute Oncology Forums To offer a group voice and collective opinion on matters relating to Acute Oncology Nursing. To provide support and guidance by connecting acute oncology nurses across the UK. To promote and facilitate the sharing of good practice. To work together as a forum to develop guidelines, practical tools and pathways to aid in the implementation of first class acute oncology services. To provide a resource for the health community by gathering a pool of expertise all can access. To support education and showcase excellent practice through workshops, study days etc. To support multi agency project working with professional organisations such as the Macmillan Cancer Support and the Royal Colleges. 17
18 Existing forums There are a number of regional forum in existence UKONS launched a national group in November Now has 600+ on the distribution list National Multi Disciplinary directory currently being collected to support the work of the National Group. Developments to date. 18
19 24 Hour Helpline Assessment 37 Progress A tool that will determine the patient s level of risk and prioritise the level of urgency indicated by the presenting symptoms and will aid in identifying potential emergency situations Uptake continues at a pace in both the NHS and Private sector in the UK and internationally 160 trusts known (please look at the map). The Pilot of the Paediatric version developed in partnership with the RCN is almost complete, evaluation is underway. Review and update in 2014 expand scope. 19
20 Primary Care Triage Services Shropshire care coordination and GP out of hours service. Macmillan funded pilot. DH funded pilot in Scotland with NHS24. Very positive results to date. A Primary Care version A Primary Care version has been developed in collaboration with Macmillan GP s and Nursing forum. It is now available as a PDF or hard copy. Really well received by the Primary Care Teams. 20
21 UKONS Primary Care Guidelines generic guidelines supported by Macmillan. Will be available as a pocket tool for order on the Macmillan web-site with the facility to add trust contact details. Developed by UKONS and The Macmillan GP Team Approved by: Greater Midlands Cancer Network. Midlands Acute Oncology Nurses Forum. Electronic version and App in development. INSTRUCTIONS FOR USE The UKONS 24 Hour Triage Tool is a widely utilised recognised tool that is used to a perform risk assessment for patients who have : Received systemic anti-cancer therapy including chemotherapy in the previous 6-8 weeks Radiotherapy Disease related immunosuppressuon It is a simple reliable evidence based process that grades the toxicities according to the advises action accordingly. It is important that the effects of treatment are of lower level amber toxicites is recognised. Risk assessment process There are a number of questions to ask and information that will need to be collected to make sure that the correct advice is given. Step 1. The user moves methodically down the triage assessment tool, asking appropriate questions. e.g. do you have any nausea? If NO move on. If YES use the questions provided to help you grade the problem and note either amber or red and initiate action according to step 2. Step 2. Red and/or Amber: If your patient scores RED or Amber for any toxicity you should contact the 24 Hour Helpline immediately for a full triage assessment unless URGENT referral to A&E is advised. Patients may require urgent assessment in a suitable clinical area that provides access to investigation and treatment facilities. The helpline team will arrange assessment and/or further monitoring for the patient. Green:- If your patient scores green in all toxicities they should be reassured that the problem at present does not give cause for concern but they should be vigilant and if the situation gets worse or does not improve they should call the Helpline immediately. ONCOLOGY/HAEMATOLOGY RISK ASSESSMENT TOOL FOR PRIMARY HEALTH CARE PROFESSIONALS Fever and/or generally unwell and recieved systemic anticancer therapy (chemotherapy oral or I.V.) within the last 6 weeks or disease related immunosuppression Anorexia What was their weight before? What is appetite like? Any contributory factors e.g. dehydration, diarrhoea, vomiting, mucositis, and nausea? Bleeding Is it a new problem? Is it continuous? What amount? Where from? Is the patient on anticoagulants? Bruising Is it a new problem? Is it local/generalised? Is there any trauma involved? Chest Pain Onset? What makes it worse? Radiation? Any cardiac history? Constipation How long since bowels opened? What is normal? Does the patient have any abdominal pain/vomiting? Has the patient taken any medication? Consider obstruction and/or perforation Diarrhoea Consider infection! TOXICITY How many days has this occurred for? How many times in a 24 hour period? Does the patient have any abdominal pain/discomfort? For how long? Has the patient taken any medication? N.B If taking CAPECITABINE (Xeloda) chemotherapy please ask patient to discontinue treatment until they have had helpline review. Dyspnoea/Shortness of breath Is it a new symptom? Is dyspnoea worsening? What can the patient do? (alteration in Performance status) Consider SVCO/Anaemia/Pulmonary ebolism Extravasation - drug leakage around infusion site or along infusion pathway Has the patient got pain, soreness or ulceration around or along the infusion pathway/injection site/central venous catheter? Fatigue How many days has this occurred for? Any other associated symptoms? Fever Patients who are at risk of immunosuppression who have an abnormal temperature should be referred to the helpline for assessment If your patient scores RED or AMBER for any toxicity you should contact the 24 Hour Helpline immediately for a full triage assessment. If temperature is 37.5 C or above or below 36 C or generally unwell - Contact telephone helpline for URGENT Assessment - Risk of neutropenic sepsis ALERT - Patients on steroids/analgesics or dehydrated may not present with pyrexia but may still have infection (if in doubt phone for advice) None None None None None None None None Loss of appetite without alteration in eating habits Mild, self limited controlled by conservative measures Petechia/bruising, localised Mild - no bowel movement in last 24 hours Advise - Dietary advice, supportive medication Increase to 2-3 bowel movements a day or over pre-treatment movements No new symptoms Intravenous therapy Certain chemotherapy drugs can cause long term severe tissue damage if extravasation (leakage) occurs. Chemotherapy extravasation requires urgent specialist review and management. Increased fatigue but not altering normal activities Advise - Rest accompanied with intermittent mild activity Oral intake altered without malnutrition Moderate petechia/purpura Generalised bruising Arrange URGENT A&E attendance for medical assessment A number of chemotherapy drugs are cardio toxic urgent assessment is essential. Moderate - no bowel movement in last 48 hours Increase to 4-6 episodes a day or nocturnal movement/ moderate cramping Dyspnoea on exertion Moderate or causing activities Oral intake altered in weight loss/malnutrition Uncontrolable haemorrhage - Arrange URGENT A&E attendance for medical assessment Generalised petechia/purpura Generalised bruising Severe - no bowel movement in last 72 hours. Consider bowel obstruction and/or perforation. Increase to 7-9 episodes a day or incontinence Severe cramping Dyspnoea at normal level of activity Severe loss of ability to perform some activities Life threatening complications e.g collapse Life threatening sepsis Consider bowel obstruction and/or perforation. Increase to > 10 episodes a day or grossly bloody diarrhoea or need for parenteral support Dyspnoea at rest or requiring ventilatory support Bedridden or disabling Normal n/a > 37.5 C - 38 C > 38 C - 40 C > 40 C Patient versions North of England Cancer Network Patient held Chemotherapy record ( Lilly diary) Cancer Emergency Response Tool,an app for patients Dr. Richard Osborne,Dorset Cancer Centre 21
22 CERT APP is now live in itunes, you can download it below. Initial assessment and management. 22
23 Initial Management Guidelines Generic management guidelines for chemotherapy toxicities (see specific algorithms for management of each toxicity) Grade 1 (Green) Grade 2 (Amber) Grade 3 (Red) Grade 4 (Red) Mild Moderate Severe Life threatening Also consider factors which lower threshold for inpatient admission: Symptoms needing urgent admission temperature, chest pain, bleeding? Might be neutropenic? More than one Grade 2 toxicity? Poor historian/ difficult to assess on phone? Compliance of patient / ability to understand and follow instructions Grade 2 toxicity not settling despite maximal outpatient efforts? Becoming weak/dehydrated? ACTION: Grade 1 See specific toxicity guidelines ACTION: Grade 2 See specific toxicity guidelines ACTION: Grade 3 and 4 NB Neutropenic sepsis needs urgent admission and immediate iv broad spectrum antibiotics/fluids. Do not get GP out first. Do not wait for FBC before giving antibiotics. See specific guideline for further detail. Admit for assessment, investigation and parenteral management. UKONS- generic initial management guidelines. RAG rated assessment and guide for early management. Available for local adaptation. Meets peer review requirements Advise patient to phone back if getting worse Document call and advice given Assess for admission if two grade 2 toxicities or toxicity not settling despite initial advice Advise patient to phone back if getting worse See specific toxicity guidelines and sections on management of inpatients with chemotherapy toxicities on page 3 If not needing admission, ensure FBC, U+E checked, good oral intake and daily contact with patient until improving, with low threshold for admission. Phone/review patient Document call and advice given and inform specialist within 24 hours to ensure team settling NB rapid deterioration possible. Chemotherapy Document call and advice toxicities are reversible but need aggressive given management Please ensure that your Acute Oncology Team are informed of the patients admission as soon as possible (As well as not instead of trust toxicity prevention and management policies) Midlands Acute Oncology Nurses Forum UNPLANNED ADMISSION LOG SHEET Standardised Assessment Process Evidence Based Assessment Tool Check List/aid memoir Audit Tool Record Keeping Evidence of practice Training and education Communication tool 23
24 Midlands Acute Oncology Nurses Forum Macmillan Learn Zone Macmillan are kindly supporting a Special Interest Group for the Midlands Acute Oncology Nurses Forum on Learn Zone. This provides a forum discussion facility and a document library allowing us to share good practice and seek opinion and/or advice. This is not restricted to nurses working within the Midlands you are all welcome to join and make use of this facility. Accessing the Acute Oncology Special Interest Group on Learn Zone - Go to : In the green bar click on special interest groups It will ask you to enrol-click continue You will need to either log in or create an account. It will then list the special interest groups, select: Midlands Acute Oncology Nurses Forum For first time access the password is ---MidA0N ( the 0 is a zero) 24
25 Forum members are working alongside Macmillan to complete an online Acute Oncology Induction Training Programme. A web based Generic Acute Oncology Induction Training Programme. Developed by Acute Oncology Nurses and Macmillan using the East Midlands Cancer Network template. Due to be launched end of
26 In the pipeline MSCC patient information MSCC Care and management plan The message is getting through! 26
27 National Developments National working party linked to Chemotherapy Reference Group (CRG):- England - National Acute Oncology Service Specification National Outcome Measures Review of current service provision- what's out there? is it working? Are the PEER review measures appropriate? How do we take the service forward The message Avoid repetition. Don t work in isolation. Don t keep good things to yourself Lets work together, join forces. Standardise and share Support each other Nationally contribute and collaborate. 27
28 Remember AOS brings together expertise from oncology disciplines, emergency medicine, palliative care, general medicine, general surgery and the community Why do we need to succeed? 28
29 Patient contacted chemotherapy helpline symptoms described in line with spinal cord compression. Advised to ring 999 for assessment in ED. Patient contacted help line again 3 days later condition worse had attended ED as directed previously but was discharged after a 5 hour wait. Patient now immobile. Patient was later admitted to ward and treated for MSCC. 57 Patient receiving chemotherapy with a history of neutropaenic sepsis following each previous cycle of treatment. Telephoned A&E for advice as she had a raised temperature. She was advised to take regular paracetamol and to report if temperature of c whilst on paracetamol. Patient presented at chemotherapy clinic, unwell, pyrexia c and neutrophils 0.1x10x9/L. Immediate admission for treatment of neutropaenic sepsis
30 The patient was discharged post chemotherapy with recovering blood counts. The Clinical Nurse Specialist contacted the patient and gave them aftercare advice and the emergency contact number. When the patient became pyrexial 38 0 c he followed CNS advice and contacted the Helpline number/ward. The person who took the call told him to take some paracetamol. 59 Any questions? Thank you 30
31 31
Training Pack 24 HOUR TRIAGE RAPID ASSESSMENT AND ACCESS TOOL KIT
Training Pack 24 HOUR TRIAGE RAPID ASSESSMENT AND ACCESS TOOL KIT The training pack aims to; provide background information regarding the aims and objectives of the tool kit. provide an explanation and
More information2.0 Development Process Aims and Objectives The Pilot Project completion Conclusion and Recommendation 28.
EVALUATION Author Philippa Jones Chairperson, UKONS Central West Chemotherapy Nurses Group Network Lead Chemotherapy Nurse/Chemotherapy Redesign Manager Greater Midlands Cancer Network CONTENTS:- Page
More informationPATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title
Patient identifier/label: Page 1 of 5 GENERIC CONSENT FORM Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other identifier) Male Female Special requirements
More information1. The appointment of two new lead Acute Oncology Nurses (AON)
Salisbury Foundation Trust Acute Oncology Service Annual Report 2014-2015 Achievements We are pleased to report our achievements this year. This is reported to the departmental Haematology/oncology/palliative
More informationDEVELOPMENTS IN ACUTE ONCOLOGY DR ERNIE MARSHALL CLATTERBRIDGE CANCER CENTRE
DEVELOPMENTS IN ACUTE ONCOLOGY DR ERNIE MARSHALL CLATTERBRIDGE CANCER CENTRE AO: WHERE WERE WE? (2009) NCEPOD 2008: Lack of Expertise Leadership Dislocated care Lack of oncologists Poor communication
More informationJob Description. Job title: Uro-Oncology Clinical Nurse Specialist Band: 7
Job Description Job title: Uro-Oncology Clinical Nurse Specialist Band: 7 Department: Cancer Services Hours: 37.5 (min 22.5 hrs) Reports to: Lead Nurse for Cancer We are a pioneering research active organisation
More informationJob Description. Job title: Gynae-Oncology Clinical Nurse Specialist Band: 7. Department: Cancer Services Hours: 30
Job Description Job title: Gynae-Oncology Clinical Nurse Specialist Band: 7 Department: Cancer Services Hours: 30 Reports to: Lead Nurse for Cancer We are a pioneering research active organisation and
More informationOpen and Honest Care in your local Trust
Agenda Item: 3 Encl. 3.3 Open and Honest Care in your local Trust Open and Honest Report for Black Country Partnership NHS Foundation Trust February 2017 NHS England INFORMATION READER BOX Directorate
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Lenvatinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cetuximab (+/- Chemotherapy) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
More informationSerious Incident Report Public Board Meeting 28 July 2016
Serious Incident Report Public Board Meeting 28 July 2016 Presented for: Presented by: Author Previous Committees Governance Dr Yvette Oade, Chief Medical Officer Louise Povey, Serious Incidents Investigations
More informationLinking the LAS with Health & Social Care. 6 th December 2016
Linking the LAS with Health & Social Care 6 th December 2016 Outline: About me.. LAS Context Integrating LAS with H&SC London Ambulance Service NHS Trust 2 LAS context London Ambulance Service NHS Trust
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT EMCN UNIVERSITY HOSPITALS OF LEICESTER Leicester Royal Infirmary Acute Oncology MDT (11-3Y-1) - 2011/12 Date Self Assessment Completed
More informationNorth Central London Sustainability and Transformation Plan. A summary
Sustainability and Transformation Plan A summary N C L Introduction Hospitals, local authorities, GPs, commissioners, and mental health trusts across north central London have all come together to transform
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine-Doxorubicin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cetuximab (+/- platinum-based chemotherapy) HOSPITAL NAME/STAMP: PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH:
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.
Patient identifier/label: Page 1 of 6 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION
Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital
More informationCollaborative Working to reduce hospital admissions. Dr Firdaus Adenwalla Annette Davies Beth Griffiths
Collaborative Working to reduce hospital admissions Dr Firdaus Adenwalla Annette Davies Beth Griffiths Ageing population A third of babies born in the UK in 2013 are expected to live to be a 100. (Office
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Lomustine PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
More informationCyclophosphamide INFUSION Infusion 4 Plus
Cyclophosphamide Infusion Day DEPARTMENT OF RHEUMATOLOGY DAY CASE ADMISSION RECORD PATIENT DAY CASE BOOKING REQUEST To be completed by Consultant, Registrar requesting day case Admission Hospital No. Forename
More informationOverall rating for this trust Good. Inspection report. Ratings. Are services safe? Requires improvement. Are services effective?
Barnsley Hospital NHS Foundation Trust Inspection report Gawber Road Barnsley South Yorkshire S75 2EP Tel: 01226 730000 www.barnsleyhospital.nhs.uk Date of inspection visit: 17 to 19 October, 15 to 17
More informationOPERATIONAL POLICY for the day case and outpatient Cancer Care and Haematology Unit, Stoke Mandeville Hospital
OPERATIONAL POLICY for the day case and outpatient Cancer Care and Haematology Unit, Stoke Mandeville Hospital Based on present services with future services in italics Date: October 2013 Review date:
More informationAcute Oncology Service (AOS) Information for patients, relatives and carers
Acute Oncology Service (AOS) Information for patients, relatives and carers page 2 This leaflet has been written to give you information about the Acute Oncology Service (AOS). This service is based at
More informationYou and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath Nursing A guide for patients and carers Contents What is a TIVAD?... 1 Why is a TIVAD necessary?... 2 How a TIVAD is inserted...
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine-Cisplatin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationGeneral Practice Triage: An update for Reception & Clinical Staff
General Practice Triage: An update for Reception & Clinical Staff October 2017 Magali De Castro Clinical Director, HotDoc This update will cover Essential components of a robust triage system Accreditation
More informationHealth and care services in Herefordshire & Worcestershire are changing
Health and care services in Herefordshire & Worcestershire are changing An update on a five year plan to provide safe, effective and sustainable care in our area www.yourconversationhw.nhs.uk Your Health
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Vinorelbine (oral) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationChemotherapy services at the Cancer Centre at Guy s
Chemotherapy services at the Cancer Centre at Guy s This leaflet aims to give you an overview of chemotherapy services at the Cancer Centre at Guy s. Chemotherapy services are delivered in two areas: Chemotherapy
More informationExperience of inpatients with ulcerative colitis throughout
Experience of inpatients with ulcerative colitis throughout the UK UK inflammatory bowel disease (IBD) audit Executive summary report June 2014 Prepared by the Clinical Effectiveness and Evaluation Unit
More information@ncepod #tracheostomy
@ncepod #tracheostomy 1 Introduction Tracheostomy: Remedy upper airway obstruction Avoid complications of prolonged intubation Protection & maintenance of airway The number of temporary tracheostomies
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas
More informationSepsis guidance implementation advice for adults
Sepsis guidance implementation advice for adults NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation
More informationCOPD Management in the community
COPD Management in the community Anne Jones Independent Respiratory Nurse Consultant RN,BSc(Hons),PGDip(RespMed)/MA Content of session Will consider the impact of COPD COPD Strategy recommendations and
More informationORGANISATIONAL AUDIT
[Type text] National Care of the Dying Audit Hospitals (NCDAH) Round 3 This audit is being led by the Marie Curie Palliative Care Institute Liverpool in collaboration with the Royal College of Physicians,
More informationBowel Screening Wales Information booklet for care homes and associated health professionals. Available in other formats on request. October.14.v.2.
Bowel Screening Wales Information booklet for care homes and associated health professionals Available in other formats on request October.14.v.2.0 Contents Section 1 Page 3 Who are Bowel Screening Wales
More information6: What care is available?
6: What care is available? This section identifies and explains the types of care on offer at end of life and who is involved. The following information is an extracted section from our full guide End
More information#NeuroDis
Each and Every Need A review of the quality of care provided to patients aged 0-25 years old with chronic neurodisability, using the cerebral palsies as examples of chronic neurodisabling conditions Recommendations
More informationOpen and Honest Care in your local Trust. Open and Honest Report for. Black Country Partnership NHS Foundation Trust
Open and Honest Care in your local Trust Open and Honest Report for Black Country Partnership NHS Foundation Trust May 2016 NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations
More informationRecognising a Deteriorating Patient. Study guide
Recognising a Deteriorating Patient Study guide Recognising a deteriorating patient Recognising and responding to clinical deterioration Background Clinical deterioration can occur at any time in a patient
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s
More informationSystemic Anti-Cancer Therapy Delivery. June 2017 National External Review
Systemic Anti-Cancer Therapy Delivery June 2017 National External Review Healthcare Improvement Scotland is committed to equality. We have assessed the review process for likely impact on equality protected
More informationFULL TEAM AHEAD: UNDERSTANDING THE UK NON-SURGICAL CANCER TREATMENTS WORKFORCE
FULL TEAM AHEAD: UNDERSTANDING THE UK NON-SURGICAL CANCER TREATMENTS WORKFORCE DECEMBER 2017 Publication date 04/12/17 Registered Charity in England and Wales (1089464), Scotland (SC041666) and the Isle
More informationMDT Peer Review Report Proforma
Network Trust NICaN Western Health and Social Care Trust Lung MDT Visit Date 13 September 2017 Structure and function of the service The Western Health and Social Care Trust (WHSCT) was established on
More informationNational Care of the Dying Audit Hospitals (NCDAH) Round 3
National Care of the Dying Audit Hospitals (NCDAH) Round 3 This audit is being led by the Marie Curie Palliative Care Institute Liverpool in collaboration with the Royal College of Physicians, and is supported
More informationDeveloping an urgent care strategy for South Tees how you can have your say July/August 2015
Developing an urgent care strategy for South Tees how you can have your say July/August 2015 Foreword Commissioning high quality, accessible urgent care services is a high priority for South Tees Clinical
More informationIntegrated heart failure service working across the hospital and the community
Integrated heart failure service working across the hospital and the community Lynne Ruddick Professional Lead (South) British Heart Foundation 31st October 2017 Heart Failure is an epidemic. NICE has
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Managing neutropenic sepsis in secondary and tertiary care bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly
More informationHOME TREATMENT SERVICE OPERATIONAL PROTOCOL
HOME TREATMENT SERVICE OPERATIONAL PROTOCOL Document Type Unique Identifier To be set by Web and Systems Development Team Document Purpose This protocol sets out how Home Treatment is provided by Worcestershire
More informationPatient Sticker Blood Transfusion Ambulatory Emergency Care Pathway
Patient Sticker Blood Transfusion Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open:
More informationNational Standards Assessment Program. Quality Report
National Standards Assessment Program Quality Report - March 2016 1 His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), Governor-General of the Commonwealth of Australia, Patron Palliative
More informationGuidance on the Enhanced Recovery Programme in Colorectal Surgery Surgery Patient Information Leaflet
Guidance on the Enhanced Recovery Programme in Colorectal Surgery Surgery Patient Information Leaflet Originator: Mr Raj Patel Date: May 2011 Version: 2 Date for Review: May 2014 DGOH Ref No: DGOH/PIL/00364
More informationSCHEDULE 2 THE SERVICES Service Specifications
SCHEDULE 2 THE SERVICES Service Specifications Service Specification No Service ParaDoc Commissioner City and Hackney CCG Commissioner Lead Leah Herridge Provider CHUHSE Provider Lead Date of Review September
More informationCARLISLE HOUSE SURGERY WINTER NEWSLETTER 2014
CARLISLE HOUSE SURGERY WINTER NEWSLETTER 2014 Welcome to the Winter Edition of our newsletter. We wish all our patients a Merry Christmas and Happy and Healthy New Year. As you know the doctors, staff
More informationPost-operative and Discharge Pathways for PBM Claire L J Atterbury CNS Transfusion and Haematology
Post-operative and Discharge Pathways for PBM Claire L J Atterbury CNS Transfusion and Haematology 1 Plan for the worst and hope for the best claire.atterbury@qehkl.nhs.uk 2 Where were we? What year? The
More informationPlans for urgent care in west Kent:
Plans for urgent care in west Kent: Introduction and background A summary of our draft strategy NHS West Kent Clinical Commissioning Group (CCG) is working to improve urgent care services and we would
More informationHickman line insertion in the interventional radiology department
Hickman line insertion in the interventional radiology department This leaflet explains more about what a Hickman line is, how it is inserted into the body and why your doctor has recommended this for
More informationAn introduction to the multi-disciplinary team for bowel and anal cancer
An introduction to the multi-disciplinary team for bowel and anal cancer Providing support for patients and their families at the Royal Sussex County Hospital An introduction to the Multidisciplinary team
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX) Patient s surname/family name Patient s first names Date of birth Hospital
More informationCRITICAL CARE OUTREACH TEAM AND THE DETERIORATING PATIENT
CRITICAL CARE OUTREACH TEAM AND THE DETERIORATING PATIENT Outreach Objectives To avert or ensure more timely admission to DCCQ To ensure that patients discharged from Critical Care continue to progress
More informationRegulation STUDENTS August 13, Management of Students with Cancer in the School Setting
August 13, 2008 Management of Students with Cancer in the School Setting These are guidelines to follow when the school is informed of the presence of a student with a cancer diagnosis. I. Modern advanced
More informationChemotherapy Training and Assessment Framework for Registered Nurses
Chemotherapy Training and Assessment Framework for Registered Nurses Document Control Prepared By Issue Date Approved By Review Date Version Contributors Comments/ Amendment Jane Beveridge January 2012
More informationBristol CCG North Somerset CGG South Gloucestershire CCG. Draft Commissioning Intentions for 2017/2018 and 2018/2019
Bristol CCG North Somerset CGG South Gloucestershire CCG Draft Commissioning Intentions for 2017/2018 and 2018/2019 Programme Area Key intention Primary and community care Sustainable primary care Implement
More informationThe Oncology Project Year 3
The Oncology Project Year 3 Dr Alison Brewster Consultant Clinical Oncologist, Velindre Hospital Introduction to the Oncology Project Why is it important? Learning objectives Process Tutorials Patient
More informationSERVICE SPECIFICATION
SERVICE SPECIFICATION Service Rotherham Hospice Lead Gail Palmer Provider Lead Paula Hill / Mike Wilkerson Period 21 st July 2010 20 th July 2013 1. Purpose This specification describes the services which
More informationReferral Handbook A guide to referral criteria for St Ann s Hospice services
Referral Handbook A guide to referral criteria for St Ann s Hospice services Inpatient Care Day Therapy Community Support St Ann s Hospice St Ann s Road North, Heald Green, Cheadle, Cheshire SK8 3SZ Tel:
More informationSeven Day Services Clinical Standards September 2017
Seven Day Services Clinical Standards September 2017 11 September 2017 Gateway reference: 06408 Patient Experience 1. Patients, and where appropriate families and carers, must be actively involved in shared
More informationCHEMOTHERAPY TREATMENT RECORD
CHEMOTHERAPY TREATMENT RECORD Consultant.. Name DOB.. Hospital Number. PRIMARY DIAGNOSIS MDT discussion date.. Consent for treatment obtained Yes / No Consent Form signed Yes / No (If no do not give Chemotherapy
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB
Patient identifier/label: Page 1 of 6 FORM CHOP 21 + RITUXIMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital
More information*Your Name *Nursing Facility. radiation therapy. SECTION 2: Acute Change in Condition and Factors that Contributed to the Transfer
Gaining information about resident transfers is an important goal of the OPTIMISTC project. CMS also requires us to report these data. This form is where data relating to long stay transfers are to be
More informationNational clinical audit of inpatient care for adults with ulcerative colitis
National clinical audit of inpatient care for adults with ulcerative colitis UK inflammatory bowel disease (IBD) audit Executive summary report June 2014 Prepared by the Clinical Effectiveness and Evaluation
More information1 Introduction 2 2 Definitions of levels of care 3 3 Common principles 4 4 Admission criteria 5 5 Referral procedure
ADMISSION & DISCHARGE POLICY FOR ADULT CRITICAL CARE SERVICES CONTENTS Page 1 Introduction 2 2 Definitions of levels of care 3 3 Common principles 4 4 Admission criteria 5 5 Referral procedure 5-7 5.1
More informationWorcestershire Acute Hospitals NHS Trust
Worcestershire Acute Hospitals NHS Trust Worcestershire Royal Hospital Quality Report Charles Hastings Way Worcester WR5 1DD Tel: 01905 763333 Website: www.worcsacute.nhs.uk Date of inspection visit: 12,
More informationUHBristol Trustwide Neutropenic Sepsis Audit. Krishna Garadi Julia Hardwick Ruth Hendy Anna Kuchel Tara Shine Sam Wells
UHBristol Trustwide Neutropenic Sepsis Audit Krishna Garadi Julia Hardwick Ruth Hendy Anna Kuchel Tara Shine Sam Wells Background Cancer Peer Review measure for Acute Oncology Door to needle time for suspected
More informationMALNUTRITION UNIVERSAL SCREEING TOOL (MUST) MUST IS A MUST FOR ALL PATIENTS
MALNUTRITION UNIVERSAL SCREEING TOOL (MUST) MUST IS A MUST FOR ALL PATIENTS Eimear Digan Senior Dietitian, Tallaght Hospital Groups at Risk of Pressure Ulcers Critically ill. Neurologically compromised
More informationSupporting people who need Palliative and End of Life Care in the Community. Giving people a choice
Supporting people who need Palliative and End of Life Care in the Community Giving people a choice Introduction People who are terminally ill or at the end of their life need excellent nursing and medical
More informationNHS 111 specification
NHS 111 specification Contents NHS 111 Specification introduction 2 Vision/aims of NHS 111 3 NHS 111: The basics 3 Who is NHS 111 for? 3 What patients can expect the new service to do: 3 Basic service
More informationNHS LOTHIAN Standard Operating Procedure: EHSCP Physiological Observations of Patients in the Community Setting
NHS LOTHIAN Standard Operating Procedure: EHSCP Physiological Observations of Patients in the Community Setting 1. Introduction To standardise the type and frequency of observations to be taken on adult
More informationWessex Regional All Cause Deterioration (including Sepsis) Guidance
Wessex Regional All Cause Deterioration (including Sepsis) Guidance For Adult ( 16 non-pregnant) patients WACDG v1 11 th May 2018 Guidance includes models for the following healthcare settings Hospital
More informationThe Development of the Oncology Symptom Management Clinic
The Development of the Oncology Symptom Management Clinic Submitted by: Catherine Brady-Copertino BSN, MS, OCN Executive Director Anne Arundel Medical Center s Geaton and JoAnn DeCesaris Cancer Institute
More informationSupport services for patients with secondary breast cancer.
Sheffield Teaching Hospitals NHS Foundation Trust Support services for patients with secondary breast cancer. Secondary breast cancer pledge: working together to improve secondary breast cancer services
More informationRectal prolapse. Information for patients General Surgery
Rectal prolapse Information for patients General Surgery Introduction Our aim is for you and your family to understand as much as possible about your condition and your operation. This booklet will help
More informationOPAT CELLULITIS PATHWAY
OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES
More informationInformation for patients with gynaecological cancer. Departments of gynaecology, oncology and gynaecological oncology
Information for patients with gynaecological cancer Departments of gynaecology, oncology and gynaecological oncology This booklet gives further information about cancers of the female reproductive system
More informationInfusion Treatment A Patient s Guide
Infusion Treatment A Patient s Guide www.guthrie.org Welcome Thank you for choosing the Guthrie Cancer Center for your medical care. Our team of dedicated professionals will do everything possible to make
More informationHome administration of intravenous diuretics to heart failure patients:
Quality and Productivity: Proposed Case Study Home administration of intravenous diuretics to heart failure patients: Increasing productivity and improving quality of care Provided by: British Heart Foundation
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team MVCN LUTON AND DUNSTABLE Luton & Dunstable Colorectal MDT (11-2D-1) - 2011/12 Peer Review Visit Date 11th November 2011
More information21 March NHS Providers ON THE DAY BRIEFING Page 1
21 March 2018 NHS Providers ON THE DAY BRIEFING Page 1 2016-17 (Revised) 2017-18 (Revised) 2018-19 2019-20 (Indicative budget) 2020-21 (Indicative budget) Total revenue budget ( m) 106,528 110,002 114,269
More informationBOLTON NHS FOUNDATION TRUST. expansion and upgrade of women s and children s units was completed in 2011.
September 2013 BOLTON NHS FOUNDATION TRUST Strategic Direction 2013/14 2018/19 A SUMMARY Introduction Bolton NHS Foundation Trust was formed in 2011 when hospital services merged with the community services
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM TRASTUZUMAB (HERCEPTIN) Patient s first names.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM TRASTUZUMAB (HERCEPTIN) Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number
More informationDRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service
DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service Executive summary: The Cornwall Sustainability and Transformation Plan known as Shaping our Future will describe a new model of
More informationCommissioning for Quality and Innovation (CQUIN) Schemes for 2015/16
Commissioning for Quality and Innovation (CQUIN) Schemes for 2015/16 Goal No. Indicator Name Contract 1 Acute Kidney Injury CWS CCG Contract - National CQUIN 2a Sepsis Screening CWS CCG Contract - National
More informationModified Early Warning Score Policy.
Trust Policy and Procedure Modified Early Warning Score Policy. Document ref. no: PP(15)271 For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: All clinical
More informationHolistic Needs Assessment (HNA) for Adult Cancer Patients Guidelines
Please Note: This policy is currently under review and is still fit for purpose. Holistic Needs Assessment (HNA) for Adult Cancer Patients Guidelines Handbook to accompany these guidelines is available
More informationOperational Focus: Performance
Operational Focus: Performance Sandra Iskander Changes for 2015/16 Change of focus of 18-weeks and A&E 4-hour wait targets as recommended by Sir Bruce Keogh, Medical Director, NHS England. 18-weeks to
More information